本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.42
+0.10007.58%
盤後1.41-0.0100-0.70%18:07 EDT
成交量:289.71萬
成交額:398.96萬
市值:3.11億
市盈率:-1.16
高:1.42
開:1.33
低:1.31
收:1.32
資料載入中...
2020/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/20

重要事件披露

Current report, item 5.02
2019/11/05

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, item 1.01
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/08/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/07

重要事件披露

Current report, items 2.02 and 9.01
2019/07/30

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/22

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/22

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/01

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/24

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/24

持股變動聲明

Statement of changes in beneficial ownership of securities